Maintenance olaparib rechallenge in patients with ovarian cancer previously treated with a parp inhibitor: patientreported outcomes from the phase iiib oreo/engot-ov38 trial
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined